TY  - GEN
AU  - Griffiths,Robert I
AU  - Gleeson,Michelle L
AU  - Mikhael,Joseph
AU  - Dreyling,Martin H
AU  - Danese,Mark D
TI  - Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma
SN  - 1097-0142
PY  - 2013///0205
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Cost-Benefit Analysis
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Prognosis
KW  - Quality-Adjusted Life Years
KW  - Rituximab
KW  - SEER Program
KW  - Survival Rate
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1002/cncr.27638
ER  -